>> CRISPR-based genome editing system targets cancer cells and destroys them by genetic manipulation. A single treatment doubled the average life expectancy of mice with glioblastoma, improving their overall survival rate by 30%, and in metastatic ovarian cancer increased their survival rate by 80%. (from: aftau.org)

Published 2 weeks ago

>> Back to view ALL ARTICLES